Current issues in immunisation: National immunisation coverage - interpreting the first three quarterly reports from the ACIR

This report published in Communicable Diseases Intelligence Volume 22 Number 6, 11 June 1998, compares the methods used by the Australian Bureau of Statistics and the Australian Childhood Immunisation Registers to obtain immunisation coverage data, and outlines some of the limitations of these data.

Page last updated: 11 June 1998

A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.

An occasional report series from the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS)

Peter B McIntyre,1 Timothy C Heath,1 Edward D O'Brien,2 Brynley P Hull3

The methodology for calculating immunisation coverage from information in the Australian Childhood Immunisation Register (ACIR) has recently been described in Communicable Diseases Intelligence,1 and the third quarterly report of national immunisation coverage appears in this issue (page 122). The purpose of this report is to outline some of the limitations of these data and to emphasise the important messages from them.

Immunisation coverage estimates from the ACIR compared with the ABS

The Australian Bureau of Statistics (ABS) immunisation survey2 measured immunisation coverage by a very different method to the ACIR.1 The ABS survey was conducted by face-to-face interview of a random sample of Australian households, representative of the resident population. Although immunisation status was measured by parental report, which tends to overestimate immunisation,3 parents of 61% of children referred to immunisation records.2 By contrast, the ACIR measures coverage from information submitted by providers; the greatest problem with this method is failure to report.

Table 1 compares the third quarterly coverage estimates from the ACIR for completion of the immunisation schedule at 12 months of age, with the estimates from the 1995 ABS survey for children of the same age. In most States, the ABS estimate of Diptheria-Tetanus-Pertussis (DTP) and Oral Polio (OPV) coverage was substantially higher than the ACIR's, and it is likely that the true coverage lies somewhere between these figures. A notable exception was Queensland, where DTP coverage on the ACIR was 2% higher than estimated by the ABS. As Queensland's reporting system (VIVAS) is linked to vaccine supply, encounters are more likely to be reported to the ACIR from providers using VIVAS than from providers using the standard encounter form.4 It is likely that the ACIR coverage estimates for Queensland are closer to true coverage in that State than those for other jurisdictions.

Estimates of Hib coverage from the ACIR are 10% higher than the ABS estimates. This reflects the marked improvement in immunisation coverage between the ABS survey in 1995 (which took place less than two years after Hib was introduced into the schedule) and the period covered by the third quarterly report. It also confirms that the ACIR is able to detect large changes in immunisation coverage, such as occur with the introduction of new vaccines into the childhood schedule.

The Northern Territory is the only jurisdiction where Hib coverage, as measured by the ACIR, substantially exceeds that of DTP. There are a number of possible factors contributing to this. Firstly, the Northern Territory uses the PRP-OMP conjugate Hib vaccine, which requires only 2 doses for the primary course for all children. This may lead to both a truly higher completion rate and a spurious increase, as it is known that third dose vaccinations are less frequently reported to the ACIR.4 Secondly, Hib immunisation has been more actively promoted in the Northern Territory than in other jurisdictions.

Top of page

Evidence for under-reporting to the ACIR

In 1996, a consultancy group (Human Capital Alliance) conducted an evaluation of the ACIR.4 This included cross-checking of parent-held immunisation records amongst a sample of children recorded by the ACIR as being at least 30 days overdue in September 1996.3 This comparison showed that 27% of third dose DTP encounters were discrepant due to missing data on the ACIR,4 confirming underestimation of coverage, but not quantifying it.

The degree by which coverage is underestimated is likely to vary by State or Territory and by the pattern of immunisation provision. Published data are available from two jurisdictions with a high proportion of providers in the public sector - the Northern Territory and Victoria. In the Northern Territory, a recent audit of immunisation coverage registers found that second dose Hib and third dose DTP coverage were 94% and 89% respectively,5 compared with ACIR estimates of 59% and 67%. Reasons for underestimation in the Northern Territory include:
  • limited use of Medicare numbers as the unique identifier in Northern Territory data, which makes matching of vaccination encounters to Medicare data problematic;
  • delays in data transmission that have resulted in the exclusion of a significant proportion of Northern Territory data from the quarterly ACIR reports; and until recently,
  • reluctance by some health services to participate in the ACIR.

In Victoria, a pilot study of home immunisation, conducted in November 1996 in economically disadvantaged local government areas in Melbourne, estimated that 93% of children were up to date with immunisation at 9 or 16 months of age, compared with 84% recorded by the ACIR.6 The degree of under reporting may be greater in States with a higher proportion of general practitioner immunisation, such as New South Wales and Western Australia, and lower in areas with centralised reporting to the ACIR, such as Queensland and the Australian Capital Territory. An independent evaluation of children recorded as being overdue by the ACIR in New South Wales, based on Public Health Units, was completed in 1997. This study should provide insights into ACIR reporting in a large area with predominantly general practitioner based immunisation delivery. A similar evaluation is also planned for Western Australia in 1998.

Future developments and conclusions

Current ACIR estimates of immunisation coverage in Australia for the vaccines scheduled in the first 12 months of life are minimum estimates or a worst case scenario. The ACIR underestimates immunisation coverage because of under reporting of vaccination encounters. Delays in reporting encounters, data transfer, and data entry are less influential causes of underestimation, because the method used to calculate national immunisation coverage allows at least 6 months after the recommended age of vaccination for reports to be entered into the ACIR.1 Between the first and third quarterly cohorts, there has been a small but definite increase nationally from 75 - 77% in the proportion of children fully immunised with a primary course of DTP, Hib, and OPV vaccines. While there may have been a real improvement in immunisation coverage, it is likely that this largely represents improved reporting to the ACIR.

The introduction of additional financial incentives for general practitioner immunisation can be expected to further improve the accuracy of the ACIR estimates of coverage, and its usefulness for monitoring Australia's progress towards national immunisation targets. Despite its limitations, ACIR data are providing valuable insights into the patterns of immunisation in Australia and with improving participation, ACIR's value as a planning tool will be further enhanced.

Top of page

Table 1. Percentage of children fully immunised, by State and Territory and assessment method, assessed at 1 year of age

State
Vaccine
DTP OPV Hib
ACIR1 (%) ABS2 (%) ACIR (%) ABS (%) ACIR (%) ABS (%)
Australian Capital Territory
83
87
82
87
81
69
New South Wales
78
87
77
88
77
63
NorthernTerritory
59
85
59
70
67
70
Queensland
81
79
82
83
82
52
South Australia
81
86
81
85
81
57
Tasmania
81
87
82
91
81
63
Victoria
82
90
82
88
82
66
Western Australia
72
87
72
84
72
71
Australia
79
86
79
86
79
62

1. Australian Childhood Immunisation Register: assessment date 30/9/97 for cohort of children born between 1/7/96-30/9/96.
2. Australian Bureau of Statistics April 1995 Immunisation Survey.

Top of page

Author affiliations

1. National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS) Royal Alexandra Hospital for Children, PO Box 3515, Parramatta, New South Wales 2124, and University of Sydney.

2. National Centre for Disease Control, Department of Health and Family Services, Australian Capital Territory.

3. Family Medicine Research Unit, Department of General Practice, University of Sydney, Westmead Hospital Westmead, New South Wales.

Top of page

References

1. O'Brien ED, Sam G, Mead C. Methodology for measuring Australia's childhood immunisation coverage. Commun Dis Intell 1998;22:6-37.

2. Australian Bureau of Statistics. Children's Immunisation Australia. April 1995. ABS no.4352.0:1-16.

3. Hawe P, Wilson A, Fahey P et al The validity of parental report of vaccination as a measure of a child=s measles immunisation status. Med J Aust 1991;155:681-686.

4. Gadiel D, Ridout L, Taylor R. Human Capital Alliance. The Australian Childhood Immunisation Register: An evaluation of the first 12 months. A report commissioned by the Department of Health and Family Services, March 1997.

5. Thorman S, Merianos A. Immunisation coverage of children 12-14 months in real time. NT Comm Dis Bull 1998;4:1-4.

6. Bond L, Nolan TM, Lester RA. Home vaccination for children behind in their immunisation schedule: a randomised controlled trial. Med J Aust 1998;168:87-490.

Acknowledgements

The authors would like to thank Dr Angela Merianos, Northern Territory Health Services, for comments on the draft manuscript.

The NCIRS was established by the National Centre for Disease Control, Commonwealth Department of Health and Family Services. The Centre analyses, interprets, and evaluates national surveillance data on immunisation coverage and vaccine preventable diseases. NCIRS also identifies research priorities, and initiates and coordinates research on immunisation issues and the epidemiology of vaccine preventable diseases in Australia.

This report was published in Communicable Diseases Intelligence Vol 22 No 6, 11 June 1998.

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now

This issue - Vol 22 No 6, June 1998